Navigation Links
FlowCardia, Inc. Appoints Chris Barys Senior VP, Sales
Date:12/5/2007

SUNNYVALE, Calif., Dec. 5 /PRNewswire-FirstCall/ -- FlowCardia, Inc., a medical device company developing endovascular devices for coronary and peripheral chronic total occlusion (CTO) recanalization, today announced the appointment of Christopher R. Barys to the position of Senior Vice President, Sales. Mr. Barys comes to FlowCardia with over 16 years of experience in Medical Devices, 12 years of which have been in the interventional endovascular products field.

Most recently, Mr. Barys served as Vice President of Sales and Marketing for the Peripheral Vascular Systems business for Edwards Lifesciences where he had broad responsibility for this rapidly growing business segment. Previously, Mr. Barys held Senior Sales and Marketing positions at Johnson & Johnson's Cordis Division, Boston Scientific and U.S. Surgical.

"We are tremendously pleased that Chris will be joining FlowCardia at this important time for the Company. His extensive experience in leading large national sales forces will be very valuable as FlowCardia initiates the immediate launch of its CROSSER System to Interventional Cardiologists, Interventional Radiologists and Vascular Surgeons," said Wick Goodspeed, President and CEO of FlowCardia. "I am confident that Chris will be a substantial contributor to our commercialization success in 2008 and the coming years."

"This is an exciting time to be joining FlowCardia. I look forward to working closely with Wick and the rest of the management team at the Company," said Mr. Barys. "FlowCardia is on the cusp of rapid growth and I am enthusiastic about the opportunity to introduce a significantly less invasive therapeutic option for coronary and peripheral CTO patients."

FlowCardia, Inc. is a privately held medical device company established in 2002 to design and manufacture safe and effective, endovascular CTO recanalization systems. Additional information is available on the Company's Web Site at http://www.flowcardia.com.

CONTACT: Mark Page

Sr. Director, Marketing

FlowCardia, Inc.

408-617-0352 ext.301


'/>"/>
SOURCE FlowCardia, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. Novo Nordisk Appoints New Leader of North American Business
3. The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer
4. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. Resonant Medical Appoints New Vice President of Global Sales
7. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
8. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
9. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
10. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
11. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: